Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biopharma News
Biosimilar Deals 2025
Biosimilar Deals 2026
Biosimilars Deals 2023
Biosimilars Deals 2024
Chantal Savage
Diversity
Helen Macpherson
Intranet
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

International Patent Expertise Strengthens Pearce IP’s Life Sciences Offering

by | Jul 8, 2026

Associate and Foreign Registered Patent Attorney

Pearce IP is pleased to welcome Sarah Dieckmann as an Associate and Foreign Registered Patent Attorney, further strengthening the firm’s specialist capability in biotechnology and life sciences intellectual property.

Sarah brings more than 10 years’ experience in intellectual property law, together with a PhD in Biology and extensive international experience as a German Patent Attorney, European Patent Attorney and in-house Senior Patent Counsel for a global consumer goods company. Her background spans private practice and industry, providing clients with commercially focused intellectual property advice informed by both legal expertise and practical business experience.

Sarah advises biotechnology and life sciences companies across the full patent lifecycle, including patent drafting and prosecution, opposition proceedings, freedom-to-operate assessments, portfolio management and strategic intellectual property advice. She has particular expertise in molecular biology, microbiology, enzyme technology and genetics, helping innovators develop intellectual property strategies that support commercialisation, investment and long-term growth.

Her appointment reflects Pearce IP’s continued commitment to providing specialist intellectual property advice to the pharmaceutical, biopharmaceutical and life sciences sectors across Australia, New Zealand and international markets.

Commenting on her appointment, Sarah said:

“I am excited to join Pearce IP and work alongside a team recognised for its deep expertise in life sciences intellectual property. I look forward to helping innovative companies protect and maximise the value of their inventions as they develop and commercialise new technologies.”

Commenting on Sarah’s appointment, Pearce IP CEO & Founder, Executive Lawyer (AU, NZ), Patent Attorney (AU, NZ) & Trade Mark Attorney (AU), Naomi Pearce, said:

“Sarah’s combination of scientific expertise, international patent experience and commercial insight makes her an outstanding addition to our team. Her appointment further strengthens our ability to support biotechnology and life sciences clients with sophisticated intellectual property strategies across global markets.”

To learn more about Sarah Dieckmann and her experience, view her profile or contact her directly at sarah.dieckmann@pearceIP.law.


 

About Pearce IP

Pearce IP is a privately owned/independent, specialist, life-sciences focussed, intellectual property/law firm offering lawyers and attorneys in Australia and New Zealand.

Our lawyers and attorneys specialise in pharma, biopharma, biotech, ag-tech, food-tech, med-tech, although our work is broader than these industries.

In 2025, Pearce IP was honoured by Australasian Lawyer and New Zealand Lawyer as a Top Specialist Firm, 5 Star Employer of Choice, and the “Standout Winner” for Inclusion and Culture (<100 employees).  Pearce IP and its leaders are ranked in every notable legal directory including: Chambers & Partners, Legal 500, IAM Patent 1000, IAM Strategy 300, MIP IP Stars, Doyles Guide, WTR 1000, Best Lawyers, WIPR Leaders, Best Law Firms, among others.

Pearce IP is the only leading IP firm in Australia and New Zealand with a female founder, and is certified by WEConnect International as women owned.

 

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.